Skip to content

Noninvasive Continuous Blood Pressure Monitoring for Cesarean Delivery

Noninvasive Continuous Blood Pressure Monitoring for Preventing Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04752904
Enrollment
154
Registered
2021-02-12
Start date
2021-04-27
Completion date
2022-12-21
Last updated
2022-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Hypotension

Keywords

noninvasive continuous blood pressure monitoring

Brief summary

Noninvasive continuous blood pressure monitoring for preventing post-spinal hypotension during cesarean delivery: A randomized controlled trial

Detailed description

The aim of this study was to find out whether the incidence of hypotension during surgery can be reduced in the case of non-invasive, continuous blood pressure monitoring using the ClearSight System in patients undergoing cesarean section under spinal anesthesia, compared to the case of using conventional noninvasive blood pressure monitoring

Interventions

Non-invasive, continuous blood pressure is monitored using ClearSight Sytem

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

randomized double blind controlled trial

Eligibility

Sex/Gender
FEMALE
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult mothers who are pregnant with single fetuses over 35 weeks gestational age undergoing planned cesarean delivery under spinal anesthesia

Exclusion criteria

* Multiple fetal pregnancy * Preexisting hypertension or pregnancy-induced hypertension * Underlying heart disease * Underlying cerebrovascular disease * Known fetal anomaly * Contraindicated in spinal anesthesia * Any sign of onset of labor * Body weight \<45 kg or body weight\> 90 kg * Height \<145cm or height\> 180cm * All other cases in which researchers determine to be inappropriate for this clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Incidence of hypotension by individualized methodsFrom spinal anesthesia to deliveryHypotension was defined as: SBP\<80% of baseline SBP

Secondary

MeasureTime frameDescription
Incidence of hypotension by standard methodsFrom spinal anesthesia to deliveryHypotension was defined as MBP\<65mmHg
Time-weighted average SBP<80% of baseline SBPFrom spinal anesthesia to deliveryTime-weighted average SBP\<80% of baseline SBP
Time-weighted average MAP <65mmHgFrom spinal anesthesia to deliveryTime-weighted average MAP \<65mmHg
Incidence of intraoperative symptomatic hypotensionFrom spinal anesthesia to deliveryDefined as: hypotension plus nausea and/or vomiting and/or dizziness and/or breathlessness
Incidence of nausea, vomiting, dizziness, breathlessnessFrom spinal anesthesia to deliveryIncidence of nausea, vomiting, dizziness, breathlessness
Incidence of intraoperative HypertensionFrom spinal anesthesia to deliverySBP\> 120% of baseline SBP
Maximum, Minimum recorded SBP, DBP, MBPFrom spinal anesthesia to deliveryMaximum, Minimum recorded SBP, DBP, MBP
Cumulative duration of hypotensionFrom spinal anesthesia to deliveryCumulative duration of hypotension
Number of hypotensive episodesFrom spinal anesthesia to deliveryNumber of hypotensive episodes
Incidence of intraoperative severe hypotensionFrom spinal anesthesia to deliveryDefined as: SBP \< 70% of baseline SBP
Cumulative consumptions of vasopressorsFrom spinal anesthesia to deliveryCumulative consumptions of vasopressors
Incidence of bradycardiaFrom spinal anesthesia to deliveryHR (heart rate) \<50 bpm
Incidence of atropine useFrom spinal anesthesia to deliveryIncidence of atropine use
Minimum heart rateFrom spinal anesthesia to deliveryMinimum heart rate
Cardiac output, stroke volumeFrom spinal anesthesia to deliveryonly in ClearSight System group
The analysis of the differences between the test method (ClearSight) and reference methodFrom spinal anesthesia to deliveryBland-Altman analysis
Apgar Scoreat 1 minute after delivery and 5 minutes after delivery1 minute, 5 minutes
Umbilical arterial bloodwithin 10 minutes after deliveryArterial blood gas analysis results
Umbilical arterial pHwithin 10 minutes after delivery\<7.2
Onset time of hypotensionFrom spinal anesthesia to deliveryOnset time of hypotension

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026